Boomi, a Dell Technologies business, announced the launch of the Boomi Molecule AWS Quick Start. The Boomi Molecule is the first AWS Quick Start that enables an Integration Platform-as-a-Service (iPaaS) for Amazon Web Services (AWS).
It provides customers the ability to configure and run a Boomi Molecule on AWS at the click of a button, implementing specific AWS best practices for security and high availability.
Customers can drastically reduce the amount of time it takes for them to deploy a Boomi Molecule into their AWS environment using the Boomi Molecule AWS Quick Start.
The Boomi Molecule AWS Quick Start can reduce hundreds of manual procedures into just a few steps, so customers can build a Boomi Molecule production environment quickly and can start using it immediately.
The Boomi Molecule AWS Quick Start includes a reference architecture, as well as a deployment guide, providing easy to understand instructions on how to deploy a fully functioning Boomi Molecule cluster on AWS in less than 30 minutes.
Boomi’s low code iPaaS is designed to enable easy application and data integration for AWS customers seeking to connect, migrate, manage, and govern data across their hybrid, SaaS, and AWS applications, reducing time to configure and deploy cloud operations.
The Boomi Molecule is a single-tenant, clustered runtime that runs separate from the platform and allows multiple processes to run concurrently.
“At Boomi, we are constantly working to deliver on our goal for ultimate customer satisfaction, which is already high, and at the same time seeking to ensure accelerated business outcomes for our customers,” said Steve Wood, Chief Product Officer at Boomi.
“With the Boomi Molecule on AWS Quick Start, customers can drastically reduce their time to deploy and, as a result, their time-to-value, while benefiting from the flexibility and scalability of Boomi products.”